The findings could potentially lead to new therapies and could stop the growth of cancers
Category: News
Gossamer’s seralutinib is designed to treat pulmonary arterial hypertension and other indications
The chronic brain disease that causes seizures currently affects around 600,000 people living in the UK
The rare and fatal progressive neurodegenerative disease is estimated to affect 5,000 people in the UK
Neurological disorders, such as epilepsy or chronic pain, affect over three billion people worldwide
The INTerpath-001 trial is evaluating Moderna/Merck’s mRNA-4157 in combination with Merck’s Keytruda
The inherited disorder is caused by genetic mutations that affects haemoglobin production
Bacteroides fragilis in the gut improves immunity and immunotherapy treatment responses
The progressive neurological condition affects more than six million people worldwide
Bladder cancer, including papillary tumours, is the ninth most common cancer type worldwide